Population
Transgenic mice overexpressing angiotensinogen in renal proximal tubular cells with streptozotocin-induced…
Comparison
Insulin, RAS blockers, or hydralazine… vs Diabetic nontransgenic littermates; control cells
Design
Preclinical
Authors
Loading...
Does not support changes in clinical RAS inhibitor use; hypothesis-generating for intrarenal synergy in diabetic tubular apoptosis.
Intrarenal RAS activation and high glucose act synergistically to increase tubular apoptosis in diabetes, independent of systemic hypertension.
Liu et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: